Mounjaro® Kwikpen (Tirzepatide) in South Africa
SCOPE Certified Weight Loss Doctors
Reviewed by
Dr Amina Guffar
Medical Practitioner in Women's Health, Obesity & Aesthetics | Medical Advisor
Summary
Mounjaro® (tirzepatide) is a once-weekly injectable medication used to improve blood sugar control in adults with type 2 diabetes and is increasingly used for medically supervised weight management. Available in South Africa with a valid prescription, it is administered using the Mounjaro KwikPen for convenient at-home use.
By targeting both GLP-1 and GIP receptors, Mounjaro supports improved insulin sensitivity, appetite regulation, and meaningful weight and metabolic outcomes. Clinical studies show significant reductions in HbA1c, weight, and cardiometabolic risk factors.
Mounjaro is dispensed through pharmacies such as Clicks, Dis-Chem Pharmacies, and Medirite, with pricing varying by dose and pharmacy. Ongoing medical supervision is essential for safe and effective treatment.
Introduction
Mounjaro® (tirzepatide) is a once-weekly injectable prescription medication used to improve blood sugar control in adults with type 2 diabetes and increasingly prescribed as part of medically supervised weight management programmes. As interest in Mounjaro in South Africa continues to grow, many patients are looking for reliable information about how the treatment works, how the Mounjaro KwikPen is administered, and what it costs at local pharmacies. In South Africa, Mounjaro is typically dispensed through retail pharmacy chains such as Dis‑Chem Pharmacies, Clicks, and Medirite pharmacies.
What is Mounjaro (Tirzepatide)?
Mounjaro® is the brand name for tirzepatide, a once-weekly injectable medication that activates two key hormonal pathways:
GLP-1 (glucagon-like peptide-1) receptors
GIP (glucose-dependent insulinotropic polypeptide) receptors
This dual mechanism improves insulin sensitivity, reduces appetite, slows gastric emptying, and enhances overall metabolic control.
Mounjaro Kwikpen South Africa Price: What Influences the Cost?
The price of Mounjaro KwikPen in South Africa varies based on several factors, and the total cost of treatment is typically higher than the medication alone. While pharmacies may offer the KwikPen, pricing is not fixed and availability can be inconsistent. Importantly, patients should expect the overall treatment cost to be approximately 30–40% more when including consultations, lab tests, and follow-up care. Structured programmes like ours can help ensure reliable access to medication if clinically appropriate.
The Mounjaro Kwikpen pricing can vary depending on several factors:
Dose strength prescribed
Pharmacy dispensing fees
Stock availability
Regional pricing differences
Getting a prescription and treatment can take several steps, but with us, everything is done in one place.
See full details here.
Our weightloss programs
Mounjaro® vs Licensed Compounded Alternative Program Comparison
Program
Support level
Speed of Weight loss
Price per month
Best for
●
●
Full support and fast results
◑
◑
Budget-friendly and low side effects
●
●
Full support and fast results
●
●
Cost-effective and fast results
◑
◑
Budget-friendly and slower weight loss
●
◕
Results with fewer side effects
●
◕
Results with fewer side effects
Support Level Key: ◑ Basic Access | ● Full Access
Weight Loss Speed Key: ◑ Slower Weight Loss | ◕ Moderate Weight Loss | ● Fastest Weight Loss
*All inclusive price including medication, consultation, labs and follow ups.
KwikPen vs Vial: What’s the Difference?
Mounjaro® (tirzepatide) has been available in both single-dose vials and the newer Mounjaro KwikPen, with key differences in convenience and use. The vial required drawing up each dose with a syringe, which was less convenient and carried a higher risk of dosing errors. In contrast, the KwikPen is a pre-filled device that delivers fixed weekly doses, making it easier to use and more suitable for at-home administration, while still allowing the dose to be adjusted if needed. The vial presentation has now largely been discontinued, with supply focused on the KwikPen in most markets.
In terms of cost, both formats provided a 4-week supply and were similarly priced, although vials were sometimes slightly cheaper. The KwikPen is now the preferred option due to improved ease of use and adherence.
Mounjaro KwikPen in South Africa
In South Africa, Mounjaro is supplied in a pre-filled KwikPen device for subcutaneous injection. The Mounjaro KwikPen, which was recently released, allows for convenient once-weekly self-administration at home after proper medical instruction.
The pen is available in multiple dose strengths (2.5mg, 5mg, 7.5mg, 10mg and higher), enabling gradual dose escalation to minimize side effects and improve tolerability.
What Are the Side Effects of Mounjaro?
The most common side effects include:
Nausea
Vomiting
Diarrhea
Constipation
Reduced appetite
These effects are typically dose-dependent and often improve as the body gradually adapts to the medication. Following a well-structured, doctor-led program like ours can help minimise side effects through careful dose adjustments, monitoring, and support.
Rare but more serious risks may include:
Allergic reaction
Gallbladder disease
Hypoglycemia (particularly when used with other glucose-lowering agents)
Pancreatitis
Clinical Effectiveness
Large international studies, including the SURPASS and SURMOUNT Phase 3 clinical trial programmes, have demonstrated significant reductions in HbA1c in patients with type 2 diabetes, average weight loss of approximately 15–22% at higher maintenance doses, and improvements in cardiometabolic markers such as waist circumference and lipid profiles (1,2). As with all GLP-1–based therapies, individual outcomes vary depending on adherence, baseline metabolic health, dose optimisation, and lifestyle support.
The Importance of Medical Supervision
Tirzepatide is most effective when used as part of a structured metabolic treatment plan that includes:
Monitoring and management of possible side effects
Nutritional guidance
Behavioural modification
Regular follow-up consultations
Careful dose titration
Monitoring of metabolic markers
Long-term success depends on appropriate patient education, realistic expectation setting, and consistent clinical oversight. Treatment should always be guided by a qualified healthcare professional.
References
Sinha R, Papamargaritis D, Sargeant JA, Davies MJ. Efficacy and safety of tirzepatide in type 2 diabetes and obesity management. J Obes Metab Syndr. 2023.
Rosenstock J, et al. Greater weight loss with tirzepatide and associated cardiometabolic improvements: pooled SURPASS analysis. Diabetes Care. 2023.